2 Cheap Stocks (Below $50) to Buy and Hold Till 2032

The inexpensive valuations and rapid growth will help these Canadian companies outperform the TSX by a wide margin.

| More on:

Most Canadian stocks lost substantial value in 2022, but only a few appear attractive on the valuation front, given their ability to grow rapidly. While the uncertain macro environment and high inflation remain a concern, investors can selectively add positions in some of them. Let’s look at two cheap stocks under $50 that can bounce back sharply and deliver outsized returns over the next decade. 

Docebo

Down about 68% from its 52-week high as of writing, Docebo (TSX:DCBO)(NASDAQ:DCBO) is an attractive long-term bet. Given the notable decline, Docebo stock is trading at an EV/sales (enterprise value to sales) multiple of 4.4 — much below its historical average of over 14. While Docebo’s valuation is low, its annual recurring revenues (a measure of future revenue growth) continue to grow fast. 

Notably, despite macro concerns, its annual recurring revenue clocked more than 50% growth in the second quarter of the current fiscal year. What’s more? Docebo’s recurring revenues have had a compound annual growth rate of 66% since 2016. 

Another key highlight is the growth in its average contract value. Notably, Docebo’s average contract value was $45,000 in the second quarter — nearly four times of 2016 levels. Further, its net dollar retention rate was 113%. 

Overall, Docebo’s growing enterprise customer base, increasing deal size, land-and-expand strategy (generating higher revenues from existing customers), and a high recurring revenue base provide a solid platform for growth. Given its low valuation and attractive growth profile, investing in this tech stock will be prudent for investors to outperform the TSX.

Nuvei

Payment tech company Nuvei (TSX:NVEI)(NASDAQ:NVEI) is another exciting stock that has the potential to beat the benchmark index. Nuvei stock has lost over 77% of its value from the peak. Multiple reasons, including a short report from Spruce Point, the slowdown in growth, volatility in the crypto market, and investors’ negative outlook on tech stocks, are behind this slump. 

Despite all the concerns, Nuvei’s fundamentals remain strong. Further, Nuvei reiterating its medium-term outlook (growing revenue and volume by 30% annually) indicates that the company is very well placed to deliver stellar returns over the next decade.

Nuvei’s investments in product innovation, sales, and distribution should drive its customer base and volumes. Further, the addition of new alternative payment methods and geographical expansion bode well for growth. Also, new customer wins and growing revenues from existing customers are positives. Nuvei is also expected to benefit from its expansion into high-growth avenues and markets. 

Overall, its solid growth prospects and inexpensive valuation (Nuvei stock is trading at an EV/sales ratio of 4.7, which compares favorably to its historical average of over 15) make it an attractive investment for long-term investors. 

Bottom line 

Both these Canadian tech companies have multiple growth catalysts and will likely deliver solid financial numbers, as the macro environment improves. Further, the significant decline in these tech stocks has driven their valuation to a multi-year low, providing a solid opportunity for buying.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Sneha Nahata has no position in any of the stocks mentioned.  The Motley Fool has positions in and recommends Nuvei Corporation. The Motley Fool recommends Docebo Inc. The Motley Fool has a disclosure policy.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »